SureTrader
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

They will have to be a reverse split

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
headshrink3 Member Profile
 
Followed By 2
Posts 98
Boards Moderated 0
Alias Born 04/24/13
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2018 5:03:18 PM
RXi Pharmaceuticals to Present at the BIO CEO and Investor Conference PR Newswire (US) - 2/5/2018 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/24/2018 2:32:18 PM
RXi Pharmaceuticals Regains Compliance with NASDAQ Listing Requirements PR Newswire (US) - 1/24/2018 12:06:00 PM
RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World Conference PR Newswire (US) - 1/17/2018 7:05:00 AM
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth PR Newswire (US) - 1/16/2018 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2018 5:22:39 PM
RXi Pharmaceuticals Announces Reverse Stock Split PR Newswire (US) - 1/5/2018 12:45:00 PM
RXi Pharmaceuticals to Present at the 10th Annual Biotech Showcase Conference PR Newswire (US) - 12/29/2017 7:05:00 AM
RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with RXI-109 for Dermal Scarring PR Newswire (US) - 12/18/2017 7:05:00 AM
Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its Therapeutic T cells PR Newswire (US) - 12/11/2017 7:05:00 AM
RXi Pharmaceuticals and the Center for Cancer Immune Therapy at Herlev Hospital Announce Research Collaboration PR Newswire (US) - 12/1/2017 7:05:00 AM
RXi Pharmaceuticals Announces Positive Results with RXI-231 in Consumer Testing Program PR Newswire (US) - 11/29/2017 7:05:00 AM
RXi Pharmaceuticals and Gustave Roussy Announce Research Collaboration PR Newswire (US) - 11/13/2017 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2017 7:12:23 AM
RXi Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights PR Newswire (US) - 11/8/2017 7:05:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 7:03:50 AM
RXi Pharmaceuticals Announces Participation in Leading European Healthcare Forums and Conferences PR Newswire (US) - 11/7/2017 7:05:00 AM
RXi Pharmaceuticals to Webcast Third Quarter 2017 Financial Results on Wednesday, November 8, 2017 PR Newswire (US) - 11/1/2017 7:05:00 AM
RXi Pharmaceuticals to Present at the 2017 Annual BIO Investor Forum PR Newswire (US) - 10/11/2017 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2017 3:46:00 PM
RXi Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference PR Newswire (US) - 9/19/2017 7:05:00 AM
RXi Pharmaceuticals to Present at BioPharm America's 10th Annual International Partnering Conference PR Newswire (US) - 9/18/2017 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2017 4:32:24 PM
RXi Pharmaceuticals Announces the Departure of Dr. Alexey Eliseev as Chief Business Officer PR Newswire (US) - 9/15/2017 4:30:00 PM
headshrink3   Saturday, 07/13/13 04:49:13 PM
Re: None
Post # of 4596 
They will have to be a reverse split otherwise nothing's going to happen and continued MM.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist